Mechanism of action: «Ion trap» effect
Chloroquine belongs to the group of agents that disrupt heme metabolism. Its main target is the malaria parasite. The process of parasite destruction occurs in several stages:
- Penetration: drug molecules easily cross membranes and enter directly into the digestive vacuole of the plasmodium.
- Ionization and trapping: an acidic environment is maintained inside the vacuole. Upon entry, chloroquine becomes ionized. The ionized form loses the ability to cross lipid membranes back out, so the drug cannot escape. It gets «locked» inside, and its concentration increases dozens of times (this is the «ion trap» effect).
- Cytotoxicity: the parasite feeds on the host's hemoglobin. During digestion, an intermediate product is formed — ferriprotoporphyrin. Chloroquine binds to it and blocks its further polymerization. As a result, toxic breakdown products accumulate and kill the plasmodium from within.
Pharmacodynamics and clinical application
Although historically a broad-spectrum antimalarial, its pharmacodynamic effects are much broader. The drug exhibits potent anti-inflammatory and immunosuppressive activity.
These effects are based on a complex mechanism:
- Inhibition of phospholipase A2 enzyme activity.
- Stabilization of cell membranes.
- Pronounced antioxidant activity.
- General immunomodulation.
Due to this, the range of applications is divided into two major groups:
- Infectious diseases: treatment of amebiasis, as well as prevention and therapy of all types of malaria (if the strain is sensitive to the drug).
- Rheumatology and dermatology: treatment of photodermatoses and rheumatic diseases. For example, in rheumatoid arthritis, chloroquine is successfully used in combination with methotrexate.
Plasmodium resistance issue
The main challenge in modern infectiology is parasite resistance to treatment. The causative agent of tropical malaria (Plasmodium falciparum) has developed reliable protection against chloroquine in most endemic regions.
- Resistance mechanism: the parasite has learned to actively pump drug molecules out of its cell (the efflux process), preventing it from reaching toxic concentrations in the vacuole.
- Relevance: despite the resistance of the tropical plasmodium, the drug remains the first-line agent for treating infections caused by P. vivax, P. ovale, P. malariae, as well as sensitive strains of P. falciparum.
Side effects and contraindications
The drug is characterized by extremely slow excretion. Elimination occurs predominantly via the kidneys and takes several months for complete clearance from the body.
The use of high doses is associated with a number of serious side effects:
- Ophthalmotoxicity: one of the most severe complications. Corneal opacity and severe retinal damage (retinopathy) are possible.
- Gastrointestinal tract: direct toxic effect, impaired motility.
- Central nervous system: various neurological disorders, including psychoses and seizures.
- Skin: development of dermatitis.
- Specific toxicity: in patients with glucose-6-phosphate dehydrogenase enzyme deficiency, the drug provokes acute erythrocyte hemolysis.
Absolute contraindications: pregnancy, psoriasis, CNS disorders, as well as liver and blood system pathologies not related to malaria.
To remember the core action on the plasmodium, imagine a «trap in acid»: chloroquine enters the acidic vacuole, gets charged (ionized), loses its return pass, and is «locked» inside, poisoning the parasite with undigested heme.
Class and exam questions
Why is chloroquine used in rheumatoid arthritis if it is an antimalarial drug?
It has a complex action: inhibits phospholipase A2, stabilizes cell membranes, and provides antioxidant and immunomodulatory effects. It is usually prescribed in combination with methotrexate.
What is the «ion trap» effect?
In the acidic environment of the plasmodium's digestive vacuole, the drug becomes ionized. In this form, it cannot pass back through the lipid membrane, accumulating inside in huge concentrations.
How exactly does the malaria parasite die from chloroquine?
The drug binds to ferriprotoporphyrin and blocks its polymerization. Because of this, toxic hemoglobin breakdown products accumulate inside the parasite, killing the cell.
Why is chloroquine not always effective in tropical malaria?
The causative agent of tropical malaria (Plasmodium falciparum) in endemic areas has developed a mechanism for actively excreting (effluxing) the drug from its cells, preventing it from accumulating.
What else to study on this topic
- Mechanisms of ophthalmotoxicity development with prolonged use
- Features of combination therapy for rheumatoid arthritis with methotrexate
- Pharmacokinetics: reasons for ultra-slow elimination from the body
- Genetic glucose-6-phosphate dehydrogenase deficiency and hemolysis
- Alternative drugs for Plasmodium falciparum resistance
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Chloroquine» and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Analgesics" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.